Undetectable serum calcidiol: Not everything that glitters is gold

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is an increased awareness of the adverse consequences of nutritional vitamin D deficiency. We report a patient with chronic tophaceous gout, chronic kidney disease (CKD) Stage 3/4 and undetectable serum calcidiol who developed severe hypercalcaemia upon vitamin D supplementation despite serum 25(OH) vitamin D within the normal range. Upon recovery, serum 1,25(OH)2 vitamin D remained in the normal range despite CKD and serum 25(OH) vitamin D 6 ng/mL. Gout tophi biopsies from additional patients showed macrophage expression of 25(OH) vitamin D 1α-hydroxylase. This case illustrates the dangers of supplementing vitamin D in patients with low serum 25(OH) vitamin D and increased 1α-hydroxylase activity due to granulomatous disease. © 2012 The Author 2012.

Cite

CITATION STYLE

APA

Gallegos-Bayas, G., Pascual-Pareja, J. F., Sanchez-Niño, M. D., Manzarbeitia, F., & Ortiz, A. (2012). Undetectable serum calcidiol: Not everything that glitters is gold. Clinical Kidney Journal, 5(1), 37–40. https://doi.org/10.1093/ndtplus/sfr121

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free